Medicinal and pharmaceutical uses of seaweed natural products: A review

By A. J. Smit. Journal of Applied Phycology, 2004

832 citations recorded by the source corpus.

Subfields: Aquatic Science, Biotechnology

View Paper: https://www.semanticscholar.org/paper/480d0ca73e0a7acd5f48e8e0139776ad96e9f57b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Aquatic Science

In Biotechnology

Citations in the corpus

Concise review of green algal genus Ulva Linnaeus (2020, background): “Ulvan and ulvan derivatives also have been reported to show hypocholesterolemic and hypolipidemic effect by reducing absorption of cholesterol in the gut (Smit 2004; Li et al. 2018).”
Study of the microbial diversity and antimicrobial properties of (2010, background): “They are also rich in polysaccharides such as alginates, fucans, and laminarans which have been reported to possess potential medicinal values and are also considered as dietary fibres (Smit, 2004).”
Red and green macroalgae for fish and animal feed and human functional food development (2016, methodology): “Digenea simplex extracts containing these compounds have been used as anthelmintic agents for centuries in Japan and for the treatment of parasitic diseases such as ascariasis.((11)) These compounds”
ALGAL TRANSGENICS IN THE GENOMIC ERA 1 (2005, background): “A number of marine taxa are of major commercial value as sources of food, biochemicals, and pharmaceuticals (Smit 2004).”
Nutritional value of edible seaweeds. (2007, background): “There are a number of reviews available on the many pharmaceutical and medicinal bioactive compounds present in seaweeds.(5,6) This review focuses on the nutritional aspects of seaweeds as foods and their associated health benefits.”
Chemical interactions between marine macroalgae and bacteria (2010, background): “These biological activities might have a protective function by elimination or control of the number of pathogens, epiphytes or endophytes (Hornsey & Hide 1976b, Hoppe et al. 1979, Smit 2004, Plouguerne et al. 2008).”
A Review of Current Research into the Biogenic Synthesis of Metal and Metal Oxide Nanoparticles via Marine Algae and Seagrasses (2017, background): “Due to the presence of thesematerials, seaweeds are considered to have medicinal and pharmaceutical properties [49].”
The genus Laminaria sensu lato : recent insights and developments (2008, background): “…of cosmetics and as health drinks, seaweeds are potential suppliers of new compounds: antiviral, antibiotic, antitumour, anti-cancer or anti-inflammatory substances are of interest for medical purposes and as new drugs (e.g. Teas, 1983; Stein & Borden, 1984; Mayer & Hamann, 2002, 2005; Smit, 2004).”
High-value products from macroalgae: the potential uses of the invasive brown seaweed, Sargassum muticum (2016, background): “Halogenated furanones from Delisea pulchra are being considered as antifouling compounds (Smit 2004).”
Bioactive compounds in seaweed: functional food applications and legislation (2011, methodology): “Other bioactive properties exhibited by marine algal lectins include antibiotic, mitogenic, cytotoxic, anti-nociceptive, anti-inflammatory, anti-adhesion and anti-HIV activities (Bird et al. 1993; Mori et al. 2005; Smit 2004).”
Seasonal variation in antifungal, antibacterial and acetylcholinesterase activity in seven South African seaweeds (2007, background): “Although terrestrial biodiversity is the foundation of the pharmaceutical industry, the oceans have enormous biodiversity and potential to provide novel compounds with commercial value (Hay 1996; Smit 2004).”
Growth and Kinetics of Lactobacillus Plantarum in the Fermentation of Edible Irish Brown Seaweeds (2011, background): “Polysaccharides from seaweeds have been reported to possess biological activities of potential medicinal values in addition to their current status as a source of dietary fibres and prebiotics (Smit, 2004).”